Science Alert, 9 March 2016
One of the most promising male birth control techniques so far has just passed another major hurdle, with trials in rabbits showing that one injection can deliver safe and effective contraception to males for at least 12 months.
Read more here
American Society for Microbiology, 1st September 2015 In recent years, evidence has been building that injectable contraceptive depot medroxyprogesterone acetate (Depo-Provera or DMPA) is associated with an increased risk of HIV infection. Now a study published in the September 1st issue of mBio, an online open-access journal of the American Society for Microbiology, provides a biological...
Hi SASHA readers,
Some people have pointed out that the link in the previous post “Depo-Provera Linked to Increased HIV Risk in Africa” goes to a login page which locks them out. I found the article through google, and it turns out you can only access it in you go in that way, i.e. via google results. I was not aware of this when i posted it.
Cheers,
SASHA
Medscape, January 09, 2015
The injectable contraceptive depot medroxyprogesterone (Depo-Provera or DMPA) is associated with elevated risk for HIV infection among women in low-income or middle-income countries of sub-Saharan Africa, according to a study.
The mechanism behind a link between DMPA and HIV infection is not known.
Read more here
Oxford University Press (OUP), February 3, 2015
Fifteen million out of 16.7 million unwanted pregnancies a year could be avoided in 35 low- and middle-income countries if women had the opportunity to use modern methods of contraception, according to a study that applies to about one-third of the world’s population.
Read more here
Reuters, Mon Sep 29, 2014 10:47pm EDT
For adolescents who choose not to abstain from sex, the American Academy of Pediatrics (AAP) favors long-acting reversible contraceptives.
Read more here